Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,038 DKK | +2.39% | +1.09% | -5.61% |
May. 03 | GENMAB : A good start to 2024; guidance unchanged | |
May. 03 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.61% | 18.59B | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.59% | 21.93B | |
-12.15% | 22.34B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B | |
+288.77% | 7.98B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Denmark's Genmab To Seek US FDA Nod For Blood Cancer Therapy In H2